Form 4 for AXGN Axogen, Inc.

Accepted 2026-02-24 00:00:00 ET · period of report 2026-02-22 · accession 0000805928-26-000032 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2026-02-24	2026-02-22	AXGN	Hartley Lindsey Marie	CFO	F - Tax	$35.38	-6,704	44.5K	-13%	-$237.2K
D	2026-02-24	2026-02-22	AXGN	Hartley Lindsey Marie	CFO	A - Grant	$0.00	+17.5K	51.2K	+52%	$0
D	2026-02-24	2026-02-22	AXGN	Hartley Lindsey Marie	CFO	A - Grant	$0.00	+17.5K	17.5K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-02-22	F	D	6,704	$35.38	44,453	D	—	—	(F2) No shares were sold by the reporting person. The transaction disclosed represents shares of the issuer's Class A Common Stock withheld by the issuer in payment of the withholding tax liability incurred upon the vesting of restricted stock units ("RSUs").
2	Common	Common Stock	2026-02-22	A	A	17,500	$0.00	51,157	D	—	—	(F1) Includes 2,281 shares acquired under the Axogen Employee Stock Purchase Plan on December 31, 2025.
3	Derivative	Restricted Stock Units	2026-02-22	A	A	17,500	$0.00	17,500	D	$0.00 · — to —	17,500 Common Stock	(F3) Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock. (F4) All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on February 22, 2028 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on February 22, 2026 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.